DE69626312D1 - Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis - Google Patents

Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis

Info

Publication number
DE69626312D1
DE69626312D1 DE69626312T DE69626312T DE69626312D1 DE 69626312 D1 DE69626312 D1 DE 69626312D1 DE 69626312 T DE69626312 T DE 69626312T DE 69626312 T DE69626312 T DE 69626312T DE 69626312 D1 DE69626312 D1 DE 69626312D1
Authority
DE
Germany
Prior art keywords
urolithiasis
medicines
concrete
reduce pain
promote removal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69626312T
Other languages
English (en)
Other versions
DE69626312T2 (de
Inventor
Masuo Akahane
Yoshitaka Tomiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Publication of DE69626312D1 publication Critical patent/DE69626312D1/de
Application granted granted Critical
Publication of DE69626312T2 publication Critical patent/DE69626312T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
DE69626312T 1995-11-30 1996-11-29 Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis Expired - Lifetime DE69626312T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34659995 1995-11-30
JP34659995 1995-11-30
PCT/JP1996/003494 WO1997019700A1 (fr) 1995-11-30 1996-11-29 Nouveau medicament pour attenuer la douleur et favoriser l'elimination des calculs lies a l'urolithiase

Publications (2)

Publication Number Publication Date
DE69626312D1 true DE69626312D1 (de) 2003-03-27
DE69626312T2 DE69626312T2 (de) 2004-01-22

Family

ID=18384525

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626312T Expired - Lifetime DE69626312T2 (de) 1995-11-30 1996-11-29 Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis

Country Status (10)

Country Link
US (2) US6410560B1 (de)
EP (1) EP0872246B1 (de)
KR (1) KR19990071800A (de)
AT (1) ATE232740T1 (de)
AU (1) AU7639796A (de)
DE (1) DE69626312T2 (de)
DK (1) DK0872246T3 (de)
ES (1) ES2195021T3 (de)
PT (1) PT872246E (de)
WO (1) WO1997019700A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID24062A (id) * 1997-07-25 2000-07-06 Kissei Pharmaceutical Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing
US20040097996A1 (en) 1999-10-05 2004-05-20 Omnisonics Medical Technologies, Inc. Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode
WO2004064835A1 (en) * 2003-01-17 2004-08-05 Neurosearch A/S Use of ion channel modulating agents for treating pain
US7794414B2 (en) 2004-02-09 2010-09-14 Emigrant Bank, N.A. Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes
WO2007061114A1 (ja) * 2005-11-28 2007-05-31 Kissei Pharmaceutical Co., Ltd. 神経因性疼痛の予防又は治療用医薬組成物
US10267796B2 (en) * 2010-10-25 2019-04-23 The Procter & Gamble Company Screening methods of modulating adrenergic receptor gene expressions implicated in melanogenesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25150A (en) * 1986-06-05 1991-03-13 Ciba Geigy Ag Novel pharmaceutical preparation for topical application

Also Published As

Publication number Publication date
ES2195021T3 (es) 2003-12-01
EP0872246A4 (de) 1999-03-24
PT872246E (pt) 2003-07-31
US6376513B1 (en) 2002-04-23
KR19990071800A (ko) 1999-09-27
ATE232740T1 (de) 2003-03-15
EP0872246A1 (de) 1998-10-21
EP0872246B1 (de) 2003-02-19
AU7639796A (en) 1997-06-19
DK0872246T3 (da) 2003-06-10
US6410560B1 (en) 2002-06-25
WO1997019700A1 (fr) 1997-06-05
DE69626312T2 (de) 2004-01-22

Similar Documents

Publication Publication Date Title
HUT59313A (en) Process for producing pharmaceutical composition comprising flupirtin as active ingredient and suitable for combatting muscular tensions
DE69630947D1 (de) Mittel zur schmerzbehandlung
DE69230046T2 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
BR9507656A (pt) Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um composto
PT861081E (pt) Utilizacao de epinastina para o tratamento de dores
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
BR9702147A (pt) Composição farmacéutica uso de uma composição farmacéutica e processo para o tratamento da dor associada com escarificação periodontal e para a preparação de uma composição farmacéutica
DE69017654T2 (de) Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung.
DE59812049D1 (de) Pharmazeutische zusammensetzung zur behandlung von schlaganfall und schädel-hirn-trauma
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
BR9711225A (pt) Composi-{es de propentofilina transd-rmica para o tratamento do mal de alzheimer
DE69626312D1 (de) Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
FR2722683B3 (fr) Appareil orthopedique pour la marche et la reeducation de personnes mandicapees
EP0744176A3 (de) Arzneimittel zur Hemmung von Knochenschwund
ITRM960827A0 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
DE69120933T2 (de) Topische Anwendung von Glycosaminoglykane zur Prävention und Behandlung der Zervikal- oder Vaginalerkrankungen
KR930021178A (ko) 뼈 형성을 자극하는 약제
DE69510933D1 (de) Amidderivate und ihre therapeutische anwendung
NO982562D0 (no) Sammensetning for behandling av smerte
IT1278853B1 (it) Dispositivo distanziatore monouso per il trattamento delle artoprotesi dell'anca
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
CA2238621A1 (en) Novel drug for relieving pain and promoting the removal of calculi in urolithiasis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition